Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography.

Vespasiani-Gentilucci U, De Vincentis A, Argemi J, Galati G, Ansò E, Patti G, Picardi A.

Arch Med Sci. 2013 Aug 30;9(4):635-9. doi: 10.5114/aoms.2013.37272.

2.

Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis.

Dzielińska Z, Januszewicz A, Demkow M, Makowiecka-Cieśla M, Prejbisz A, Naruszewicz M, Nowicka G, Kadziela J, Zieliński T, Florczak E, Janas J, Januszewicz M, Ruzyłło W.

J Hypertens. 2007 Mar;25(3):663-70.

PMID:
17278983
3.

Decreased cardiotrophin-1 levels are associated with a lower risk of developing the metabolic syndrome in overweight/obese children after a weight loss program.

Rendo-Urteaga T, García-Calzón S, Martínez-Ansó E, Chueca M, Oyarzabal M, Azcona-Sanjulián MC, Bustos M, Moreno-Aliaga MJ, Martínez JA, Marti A.

Metabolism. 2013 Oct;62(10):1429-36. doi: 10.1016/j.metabol.2013.05.011.

PMID:
23856329
4.

A carotid extra-media thickness, PATIMA combined index and coronary artery disease: Comparison with well-established indexes of carotid artery and fat depots.

Haberka M, Gąsior Z.

Atherosclerosis. 2015 Nov;243(1):307-13. doi: 10.1016/j.atherosclerosis.2015.09.022.

PMID:
26414210
5.

Metabolic Syndrome.

Lam DW, LeRoith D.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 May 19.

6.

Superiority of waist circumference and body mass index in cardiovascular risk assessment in hypertensive patients with coronary heart disease.

Sobiczewski W, Wirtwein M, Jarosz D, Gruchala M.

Blood Press. 2015 Apr;24(2):90-5. doi: 10.3109/08037051.2014.986945.

PMID:
25668594
7.

Association of central obesity with early Carotid intima-media thickening is independent of that from other risk factors.

Maher V, O'Dowd M, Carey M, Markham C, Byrne A, Hand E, Mc Inerney D.

Int J Obes (Lond). 2009 Jan;33(1):136-43. doi: 10.1038/ijo.2008.254.

PMID:
19065148
8.

Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study.

Lisowska A, Knapp M, Tycińska A, Motybel E, Kamiński K, Święcki P, Musiał WJ, Dymicka-Piekarska V.

Atherosclerosis. 2016 Mar;246:309-17. doi: 10.1016/j.atherosclerosis.2016.01.022.

PMID:
26828748
9.

Microcirculatory damage of common carotid artery wall in obese and non obese subjects.

Ciccone M, Maiorano A, De Pergola G, Minenna A, Giorgino R, Rizzon P.

Clin Hemorheol Microcirc. 1999;21(3-4):365-74.

PMID:
10711772
10.

Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.

Jadhav UM, Kadam NN.

J Assoc Physicians India. 2004 May;52:370-5.

PMID:
15656025
11.

N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives.

Pastormerlo LE, Maffei S, Latta DD, Chubuchny V, Susini C, Berti S, Clerico A, Prontera C, Passino C, Januzzi JL Jr, Emdin M, Chiappino D.

Eur J Prev Cardiol. 2016 Mar;23(4):366-76. doi: 10.1177/2047487315569675.

PMID:
25644699
12.

Increased aortic pulse wave velocity is associated with the presence of angiographic coronary artery disease in overweight and obese patients.

Bechlioulis A, Vakalis K, Naka KK, Bourantas CV, Papamichael ND, Kotsia A, Tzimas T, Pappas K, Katsouras CS, Michalis LK.

Am J Hypertens. 2013 Feb;26(2):265-70. doi: 10.1093/ajh/hps039.

PMID:
23382412
13.

Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.

Zapolski T, Waciński P, Kondracki B, Rychta E, Buraczyńska MJ, Wysokiński A.

Kardiol Pol. 2011;69(4):319-26.

14.

Relationship between carotid disease on ultrasound and coronary disease on CT angiography.

Cohen GI, Aboufakher R, Bess R, Frank J, Othman M, Doan D, Mesiha N, Rosman HS, Szpunar S.

JACC Cardiovasc Imaging. 2013 Nov;6(11):1160-7. doi: 10.1016/j.jcmg.2013.06.007.

15.

[Relationship between carotid intima-media thickness, atherosclerosis risk factors and angiography findings in patients with coronary artery disease].

Kabłak-Ziembicka A, Przewłocki T, Kostkiewicz M, Pieniazek P, Mura A, Podolec P, Tracz W.

Przegl Lek. 2003;60(10):612-6. Polish.

PMID:
15052717
16.

The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.

Kadoglou NP, Gerasimidis T, Golemati S, Kapelouzou A, Karayannacos PE, Liapis CD.

J Vasc Surg. 2008 Jan;47(1):55-62. doi: 10.1016/j.jvs.2007.09.058.

17.

[Association of carotid atherosclerosis with coronary artery disease: comparison between carotid ultrasonography and coronary angiography in patients with chest pain].

Novo S, Corrado E, Novo G, Dell'Oglio S.

G Ital Cardiol (Rome). 2012 Feb;13(2):118-23. doi: 10.1714/1021.11145. Italian.

PMID:
22322552
18.
19.

Evaluation of the relations between the presence of the metabolic syndrome and the degree of visceral obesity and the severity of coronary artery disease by coronary angiography.

Lewandowski A, Dłużniewski M, Chmielewski M, Zieliński Ł, Pikto-Pietkiewicz W, Burbicka E, Modzelewski M.

Kardiol Pol. 2013;71(9):937-44.

20.

Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.

Ikonomidis I, Kadoglou NN, Tritakis V, Paraskevaidis I, Dimas K, Trivilou P, Papadakis I, Tzortzis S, Triantafyllidi H, Parissis J, Anastasiou-Nana M, Lekakis J.

Atherosclerosis. 2014 May;234(1):34-41. doi: 10.1016/j.atherosclerosis.2014.02.004.

PMID:
24594367
Items per page

Supplemental Content

Support Center